NYSSA • The New York State Society of Anesthesiologists, Inc.
Volume 78 Number 1
As the case volume of non-operating room anesthesia (NORA) continues to grow, anesthesiologists must balance patient safety, efficiency and the unique organizational challenges within NORA procedural environments. Remimazolam, an ultra-short-acting benzodiazepine, is a new drug that may be safely used in non-OR settings.
You'll have to be logged in to keep reading.
Website design, development and hosting by MAjor Designs